Lastly, IL-32 levels are elevated in the cerebrospinal fluid of patients with multiple sclerosis or neuro-Behcet’s disease [15], and a polymorphism in the IL-32 promoter has been associated with increased risk of multiple sclerosis in two independent studies [75, 76]. Here, IL32 is linked to multiple sclerosis.